Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months

Clinical trial NCT02442752 · WITHDRAWN

Trial details

NCT number: NCT02442752
Sponsor: Takeda
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Gastroesophageal Reflux Disease

Start date: 2025-06-15
Primary completion: 2025-12-23
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.